Discovery through Phase III Experience

  • Nonclinical Strategy

  • CRO Identification & Vendor Management

  • GLP Toxicology & Safety Pharmacology

  • Data Analysis

  • Lab & Vivarium Operations

  • Clinical & Translational Pharmacology

  • MOA & Biomarker Development

  • Pharmacokinetic Modeling (ADME/PK)

  • Regulatory Report Writing (IND/NDA/IB)

Next
Next

Commercialization